Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles

Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles

Glioblastoma (GBM) is the most aggressive and lethal form of brain tumor. Extracellular vesicles (EVs) released by tumor cells play a critical role in cellular communication in the tumor microenvironment promoting tumor progression and invasion. We hypothesized that GBM EVs possess unique characteri...

Full description

Bibliographic Details
Main Authors:	Wenbo Zhou, Daniel Lovasz, Zoë Zizzo, Qianbin He, Christina Coughlan, Robert G. Kowalski, Peter G. E. Kennedy, Arin N. Graner, Kevin O. Lillehei, D. Ryan Ormond, A. Samy Youssef, Michael W. Graner, Xiaoli Yu
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Biomedicines
Subjects:	extracellular vesicles glioblastoma meningioma plasma neurons IgG
Online Access:	https://www.mdpi.com/2227-9059/10/11/2718

Similar Items

Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity
by: Wenbo Zhou, et al.
Published: (2022-06-01)

Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-Talk
by: Timothy J. Kopper, et al.
Published: (2023-05-01)

Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies
by: Cholpon Tilegenova, et al.
Published: (2020-01-01)

Large haemorrhage within glioblastoma mimicking haemorrhagic stroke and coexistance of meningioma: a case of collision tumours
by: Michał Sobstyl, et al.
Published: (2023-10-01)

Specific IgG and its subclass antibodies after immunotherapy with gynandropsis gynandra
by: Latha G, et al.
Published: (2005-01-01)

Antibody isotypes, including IgG subclasses, in Ecuadorian patients with pulmonary Paragonimiasis
by: Angel Guevara E., et al.
Published: (1995-08-01)

Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1–4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies
by: Itziar Ubillos, et al.
Published: (2018-06-01)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
by: Myrthe E. Sonneveld, et al.
Published: (2018-01-01)

Antibody Profiling and In Silico Functional Analysis of Differentially Reactive Antibody Signatures of Glioblastomas and Meningiomas
by: Lisa Milchram, et al.
Published: (2023-01-01)

High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas
by: Philip D. Tatman, et al.
Published: (2021-07-01)

Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
by: Zoia R. Korobova, et al.
Published: (2022-04-01)

The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD
by: Hyun Lee, et al.
Published: (2022-05-01)

Plasma antibody levels (IgG1، IgG2) in periodontitis and control groups
by: Mosavi M., et al.
Published: (2009-03-01)

Letter to the editor. Face-off between glioma and meningioma
by: Dinesh Chouksey, et al.
Published: (2021-09-01)

Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS)
by: Piotr Kośliński, et al.
Published: (2023-11-01)

Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors
by: Cinzia Rizzo, et al.
Published: (2014-11-01)

Plasmodium falciparum VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria
by: Bernard Tornyigah, et al.
Published: (2021-04-01)

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV
by: Silvia Baroncelli, et al.
Published: (2022-04-01)

Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality
by: Susan H. Tam, et al.
Published: (2017-09-01)

Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
by: Fernando Sergio Leitao Filho, et al.
Published: (2018-02-01)

Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
by: Orit Uziel, et al.
Published: (2024-01-01)

Natural history and pathogenesis of IgG4-related disease
by: Culver, E
Published: (2015)

Evaluation of IgG4+ Plasma Cell Infiltration in Patients with Systemic Plasmacytosis and Other Plasma Cell-infiltrating Skin Diseases
by: Shintaro Takeoka, et al.
Published: (2018-02-01)

Investigation of Circulating anti- Coxsackie B, anti- Polio and anti- Adeno IgG in newly diagnosed T1DM Children
by: Eman M. Saleh, et al.
Published: (2008-01-01)

The Neonatal Fc Receptor (FcRn): A Misnomer?
by: Michal Pyzik, et al.
Published: (2019-07-01)

Avaliação das subclasses IgG1 e IgG3 na doença hemolítica perinatal
by: Maria A. Araújo, et al.
Published: (2003-01-01)

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
by: Sterre L. Siekman, et al.
Published: (2022-10-01)

Proteomic characteristics of saliva in patients with different subgroups of IgG4-RD
by: Sheng-Yan Lin, et al.
Published: (2022-11-01)

Specific IgG Antibodies (Total and Subclasses) against Saffron Pollen: A Study of Their Correlation with Specific IgE and Immediate Skin Reactions
by: Abdol-Reza Varasteh, et al.
Published: (2007-12-01)

COMPARATIVE STUDY OF SPECIFIC EBV ANTIBODIES BETWEEN CHILDREN MANIFEST CLASSIC TRIAD OF MONONUCLEOSIS WIT UNAFFECTED CHILDREN IN HAZRAT RASOOL AKRAM HOSPITAL (1998-2000)
by: Samile Noorbakhsh, et al.
Published: (2003-06-01)

Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance
by: Wei-Yi Chou, et al.
Published: (2022-11-01)

Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA)
by: Jae Keun Park, et al.
Published: (2022-05-01)

Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review
by: Johanna K. Rickel, et al.
Published: (2024-04-01)

Hemorrhage in brain tumor – An unresolved issue
by: Robert P. Ostrowski, et al.
Published: (2022-06-01)

Effect of lifestyle and dietary factors in the development of brain tumors
by: Nandini Bansal, et al.
Published: (2020-01-01)

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
by: Marjahan Akhtar, et al.
Published: (2023-12-01)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Rodrigo V. Motta, et al.
Published: (2024-02-01)

Impact of estrogen on IgG glycosylation and serum protein glycosylation in a murine model of healthy postmenopause
by: Priti Gupta, et al.
Published: (2023-09-01)

CHANGES IN THE IMMUNOLOGIC MARKERS OF COLLAGEN TYPE IV DEGRADATION IN SUBJECTS WITH METABOLIC SYNDROME
by: Edward Mekenyan, et al.
Published: (2012-12-01)